Clinical Trial Update: Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the pharmacokinetics, safety, and tolerability of three different molecular-weight formulations of depot buprenorphine in adults se…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• SUBLOCADE (buprenorphine extended-release)

Snippet

Sponsor: Indivior Inc. | Conditions: Opioid Use Disorder | Phase 1 | Status: COMPLETED